Minister of Health announced the purchase of 200 thousands dose of a treatment based on monoclonal antibodies
Germany will be the first country in the European Union to use the experimental cocktail based on monoclonal antibodies against Covid-19, with which former President Donald Trump was treated.
This was announced by the Minister of Health of Berlin, Jens Spahn, announcing the purchase of 200 thousand doses for 400 million euros that will be distributed from next week. “It works like a passive vaccination. Administration in the early stages can help high-risk patients avoid more severe progression, ”Spahn explained.
The news comes while there is tension in Europe, but not only, on the supply and distribution of vaccines, due to stops and delays. The president of the European Council, Charles Michel, also returned to this point, promising that pharmaceutical companies will have to “respect vaccine contracts”.
© Copyright LaPresse